Management of elevated serum XXXX in a university-based family practice.

@entity1 @entity1007 @entity165 @entity301
@entity1007 is a well-known risk factor of @entity301 . This study was designed to determine whether a group of family physicians in an academic medical center followed recent recommendations in the recognition and treatment of young @entity1 with elevated @entity165 levels. @entity1 charts were reviewed retrospectively in 94.1 percent of the 1,129 @entity1 aged between 30 and 39 years seen in the University of California at Los Angeles (UCLA) Family Health Center over a one-year period. Only 346, or 32.6 percent, of the charts reviewed contained the @entity1 's @entity165 values. Ninety-nine patients had serum @entity165 levels greater than the recommended treatment level of 5.70 mmol/L (220 mg/dL). Of @entity1 with elevated @entity165 levels, only 34.1 percent were treated. There was no difference in the treatment rates of faculty members' @entity1 as compared with residents' @entity1 . The incidence of treatment increased linearly with respect to rising @entity165 values. This study identified the relative infrequency with which @entity165 levels appear in the charts of @entity1 aged 30 to 39 years. It also illustrated that significantly more physician effort is required to meet suggested treatment guidelines for @entity1 with elevated @entity165 levels. The @entity165 "normal ranges" that are reported on laboratory result sheets, which are not age-specific, may be misleading, and consequently affect @entity1 care.
